LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 292 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $33,000 | 0.0% | 291 | -35.6% | 0.00% | 0.0% |
| Q1 2020 | $33,000 | -28.3% | 452 | +2.5% | 0.00% | 0.0% |
| Q4 2019 | $46,000 | +206.7% | 441 | +687.5% | 0.00% | +100.0% |
| Q3 2018 | $15,000 | -93.8% | 56 | -97.2% | 0.00% | -95.7% |
| Q2 2017 | $240,000 | -38.1% | 1,973 | -48.1% | 0.02% | -43.9% |
| Q3 2016 | $388,000 | +691.8% | 3,800 | +724.3% | 0.04% | +485.7% |
| Q1 2016 | $49,000 | +96.0% | 461 | +84.4% | 0.01% | +133.3% |
| Q2 2015 | $25,000 | -32.4% | 250 | -64.3% | 0.00% | -40.0% |
| Q4 2014 | $37,000 | +32.1% | 700 | +16.7% | 0.01% | +25.0% |
| Q3 2014 | $28,000 | -93.2% | 600 | -90.9% | 0.00% | -92.6% |
| Q2 2014 | $411,000 | – | 6,600 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |